View in EDS

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.

Saved in:
Bibliographic Details
Title: The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.
Authors: López-Gil JC; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain., García-Silva S; Microenvironment and Metastasis Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com., Ruiz-Cañas L; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Biobanco Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Navarro D; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain., Palencia-Campos A; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Giráldez-Trujillo A; Grupo de Oncología Cutánea, Servicio de Anatomía Patológica, Hospiral Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Earl J; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain., Dorado J; Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gómez-López G; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Monfort-Vengut A; Cell Cycle and Cancer Biomarkers Laboratory, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain., Alcalá S; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain., Gaida MM; Institute of Pathology, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.; TRON, JGU-Mainz, Translational Oncology at the University Medical Center, Mainz, Germany.; Research Center for Immunotherapy, JGU-Mainz, University Medical Center Mainz, Mainz, Germany., García-Mulero S; Department of Pathology and Experimental Therapy, Universidad de Barcelona Facultad de Medicina y Ciencias de La Salud, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), IDIBELL, Barcelona, Spain., Cabezas-Sáinz P; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, Universidade de Santiago de Compostela, Lugo, Spain., Batres-Ramos S; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Barreto E; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; School of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Spain., Sánchez-Tomero P; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Vallespinós M; Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Ambler L; Barts Cancer Institute, Queen Mary University of London, London, UK., Lin ML; Barts Cancer Institute, Queen Mary University of London, London, UK., Aicher A; Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan., García García de Paredes A; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Gastroenterology and Hepatology, Hospital Universitario Ramon y Cajal, Madrid, Spain., de la Pinta C; Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Sanjuanbenito A; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramon y Cajal, Madrid, Spain., Ruz-Caracuel I; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Ramon y Cajal University Hospital Anatomy Pathology Service, Madrid, Spain.; Molecular Pathology of Cancer Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Rodríguez-Garrote M; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Medical Oncology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain., Guerra C; Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Carrato A; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Medical Oncology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain., de Cárcer G; Cell Cycle and Cancer Biomarkers Laboratory, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain., Sánchez L; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, Universidade de Santiago de Compostela, Lugo, Spain., Nombela-Arrieta C; Department of Medical Oncology and Hematology, University and University Hospital Zurich, Zürich, Switzerland., Espinet E; Department of Pathology and Experimental Therapy, Universidad de Barcelona Facultad de Medicina y Ciencias de La Salud, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), IDIBELL, Barcelona, Spain., Sanchez-Arevalo Lobo VJ; Grupo de Oncología Cutánea, Servicio de Anatomía Patológica, Hospiral Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Grupo de Oncología Molecular, Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, Spain., Heeschen C; Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Candiolo (TO), Italy bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com., Sainz B Jr; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.
Source: Gut [Gut] 2024 Aug 08; Vol. 73 (9), pp. 1489-1508. Date of Electronic Publication: 2024 Aug 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38754953
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22López-Gil+JC%22">López-Gil JC</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Silva+S%22">García-Silva S</searchLink>; Microenvironment and Metastasis Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com.<br /><searchLink fieldCode="AU" term="%22Ruiz-Cañas+L%22">Ruiz-Cañas L</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Biobanco Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Navarro+D%22">Navarro D</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Palencia-Campos+A%22">Palencia-Campos A</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Giráldez-Trujillo+A%22">Giráldez-Trujillo A</searchLink>; Grupo de Oncología Cutánea, Servicio de Anatomía Patológica, Hospiral Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Earl+J%22">Earl J</searchLink>; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dorado+J%22">Dorado J</searchLink>; Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-López+G%22">Gómez-López G</searchLink>; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Monfort-Vengut+A%22">Monfort-Vengut A</searchLink>; Cell Cycle and Cancer Biomarkers Laboratory, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alcalá+S%22">Alcalá S</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid (UAM), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gaida+MM%22">Gaida MM</searchLink>; Institute of Pathology, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.; TRON, JGU-Mainz, Translational Oncology at the University Medical Center, Mainz, Germany.; Research Center for Immunotherapy, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22García-Mulero+S%22">García-Mulero S</searchLink>; Department of Pathology and Experimental Therapy, Universidad de Barcelona Facultad de Medicina y Ciencias de La Salud, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), IDIBELL, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cabezas-Sáinz+P%22">Cabezas-Sáinz P</searchLink>; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, Universidade de Santiago de Compostela, Lugo, Spain.<br /><searchLink fieldCode="AU" term="%22Batres-Ramos+S%22">Batres-Ramos S</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barreto+E%22">Barreto E</searchLink>; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; School of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Tomero+P%22">Sánchez-Tomero P</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vallespinós+M%22">Vallespinós M</searchLink>; Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ambler+L%22">Ambler L</searchLink>; Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lin+ML%22">Lin ML</searchLink>; Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Aicher+A%22">Aicher A</searchLink>; Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22García+García+de+Paredes+A%22">García García de Paredes A</searchLink>; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Gastroenterology and Hepatology, Hospital Universitario Ramon y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+la+Pinta+C%22">de la Pinta C</searchLink>; Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanjuanbenito+A%22">Sanjuanbenito A</searchLink>; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramon y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ruz-Caracuel+I%22">Ruz-Caracuel I</searchLink>; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Ramon y Cajal University Hospital Anatomy Pathology Service, Madrid, Spain.; Molecular Pathology of Cancer Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Garrote+M%22">Rodríguez-Garrote M</searchLink>; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Medical Oncology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Guerra+C%22">Guerra C</searchLink>; Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carrato+A%22">Carrato A</searchLink>; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.; Medical Oncology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+Cárcer+G%22">de Cárcer G</searchLink>; Cell Cycle and Cancer Biomarkers Laboratory, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez+L%22">Sánchez L</searchLink>; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, Universidade de Santiago de Compostela, Lugo, Spain.<br /><searchLink fieldCode="AU" term="%22Nombela-Arrieta+C%22">Nombela-Arrieta C</searchLink>; Department of Medical Oncology and Hematology, University and University Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Espinet+E%22">Espinet E</searchLink>; Department of Pathology and Experimental Therapy, Universidad de Barcelona Facultad de Medicina y Ciencias de La Salud, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), IDIBELL, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Arevalo+Lobo+VJ%22">Sanchez-Arevalo Lobo VJ</searchLink>; Grupo de Oncología Cutánea, Servicio de Anatomía Patológica, Hospiral Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Grupo de Oncología Molecular, Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, Spain.<br /><searchLink fieldCode="AU" term="%22Heeschen+C%22">Heeschen C</searchLink>; Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Candiolo (TO), Italy bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com.<br /><searchLink fieldCode="AU" term="%22Sainz+B+Jr%22">Sainz B Jr</searchLink>; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Cancer Department, Instituto de Investigaciones Biomédicas (IIBM) Sols-Morreale CSIC-UAM, Madrid, Spain bsainz@iib.uam.es sgsilva@cnio.es christopher.heeschen@icloud.com.; Biomarkers and Personalized Approach to Cancer Group (BIOPAC), Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Área Cáncer, Centro de Investigación Biomédica en Red (CIBERONC), ISCIII, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985108R%22">Gut</searchLink> [Gut] 2024 Aug 08; Vol. 73 (9), pp. 1489-1508. <i>Date of Electronic Publication: </i>2024 Aug 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985108R <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3288 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200175749%22">00175749 </searchLink><i>NLM ISO Abbreviation: </i>Gut <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38754953
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/gutjnl-2023-330995
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1489
    Titles:
      – TitleFull: The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: López-Gil JC
      – PersonEntity:
          Name:
            NameFull: García-Silva S
      – PersonEntity:
          Name:
            NameFull: Ruiz-Cañas L
      – PersonEntity:
          Name:
            NameFull: Navarro D
      – PersonEntity:
          Name:
            NameFull: Palencia-Campos A
      – PersonEntity:
          Name:
            NameFull: Giráldez-Trujillo A
      – PersonEntity:
          Name:
            NameFull: Earl J
      – PersonEntity:
          Name:
            NameFull: Dorado J
      – PersonEntity:
          Name:
            NameFull: Gómez-López G
      – PersonEntity:
          Name:
            NameFull: Monfort-Vengut A
      – PersonEntity:
          Name:
            NameFull: Alcalá S
      – PersonEntity:
          Name:
            NameFull: Gaida MM
      – PersonEntity:
          Name:
            NameFull: García-Mulero S
      – PersonEntity:
          Name:
            NameFull: Cabezas-Sáinz P
      – PersonEntity:
          Name:
            NameFull: Batres-Ramos S
      – PersonEntity:
          Name:
            NameFull: Barreto E
      – PersonEntity:
          Name:
            NameFull: Sánchez-Tomero P
      – PersonEntity:
          Name:
            NameFull: Vallespinós M
      – PersonEntity:
          Name:
            NameFull: Ambler L
      – PersonEntity:
          Name:
            NameFull: Lin ML
      – PersonEntity:
          Name:
            NameFull: Aicher A
      – PersonEntity:
          Name:
            NameFull: García García de Paredes A
      – PersonEntity:
          Name:
            NameFull: de la Pinta C
      – PersonEntity:
          Name:
            NameFull: Sanjuanbenito A
      – PersonEntity:
          Name:
            NameFull: Ruz-Caracuel I
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Garrote M
      – PersonEntity:
          Name:
            NameFull: Guerra C
      – PersonEntity:
          Name:
            NameFull: Carrato A
      – PersonEntity:
          Name:
            NameFull: de Cárcer G
      – PersonEntity:
          Name:
            NameFull: Sánchez L
      – PersonEntity:
          Name:
            NameFull: Nombela-Arrieta C
      – PersonEntity:
          Name:
            NameFull: Espinet E
      – PersonEntity:
          Name:
            NameFull: Sanchez-Arevalo Lobo VJ
      – PersonEntity:
          Name:
            NameFull: Heeschen C
      – PersonEntity:
          Name:
            NameFull: Sainz B Jr
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 08
              Text: 2024 Aug 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3288
          Numbering:
            – Type: volume
              Value: 73
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Gut
              Type: main
ResultId 1